Neuroimmunology Unit

Oct 8, 2024 | academic.oup.com | Neuroimmunology Unit

Increasing evidence indicates heterogeneity in functional and molecular properties of oligodendrocyte lineage cells both during development and under pathologic conditions. In multiple sclerosis, remyelination of grey matter lesions exceeds that in white matter.

May 21, 2024 | link.springer.com | Maria Pia |Vita-Salute San Raffaele |Neuroimmunology Unit |Tor Vergata

Correction to: Journal of Neurology (2024) 271:3879–3896 https://doi.org/10.1007/s00415-024-12426-wIn the original version of this article, in the caption of Fig. 1, in the last sentence of the legend for panel A “Eculizumab targets the C5 complement component to block complement-mediated cytotoxicity”, “and ravulizumab” should be added. The sentence should read “Eculizumab and ravulizumab target the C5 complement component to block complement-mediated cytotoxicity”.

May 20, 2024 | link.springer.com | Maria Pia |Vita-Salute San Raffaele |Neuroimmunology Unit |Tor Vergata

AbstractNeuromyelitis optica spectrum disorders (NMOSD) include a rare group of autoimmune conditions that primarily affect the central nervous system. They are characterized by inflammation and damage to the optic nerves, brain and spinal cord, leading to severe vision impairment, locomotor disability and sphynteric disturbances.

Jul 7, 2023 | frontiersin.org | Neuroimmunology Unit |Bioinformatics Unit |Demyelinating Diseases Unit |Laura Otero-Ortega

Alicia Sánchez-Sanz1,2, Santiago García-Martín3, Julia Sabín-Muñoz4, Irene Moreno-Torres5, Víctor Elvira6, Fátima Al-Shahrour3, Aranzazu García-Grande7, Elvira Ramil8, Ofir Rodríguez-De la Fuente4, Beatriz Brea-Álvarez9, Ruth García-Hernández1, Antonio García-Merino1,4,10,11*† and Antonio José Sánchez-López1,11,12*† 1Neuroimmunology Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain 2PhD Program in Molecular Biosciences, Doctoral School, Universidad...

Mar 14, 2023 | frontiersin.org | Neuroimmunology Unit

Adrià Quesada-Simó1, Alejandro Garrido-Marín2, Pilar Nos2 and Sara Gil-Perotin3, 4, 5* 1Doctor Peset University Hospital, Spain 2Gastroenterology Unit- Hospital Universitario y Politécnico La Fe, Spain 3La Fe Hospital, Spain 4Neuroimmunology Unit -University Hospital La Fe, Spain 5Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED), Spain The final, formatted version of the article will be published soon.